Avantax Advisory Services’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.13M Buy
137,959
+23,661
+21% +$366K 0.01% 768
2025
Q1
$1.7M Buy
114,298
+103,325
+942% +$1.54M 0.01% 832
2024
Q4
$145K Buy
+10,973
New +$145K ﹤0.01% 2096